Next Article in Journal
Sumac Silver Novel Biodegradable Nano Composite for Bio-Medical Application: Antibacterial Activity
Next Article in Special Issue
Duchenne Muscular Dystrophy: From Diagnosis to Therapy
Previous Article in Journal
68Ga-Based Radiopharmaceuticals: Production and Application Relationship
Previous Article in Special Issue
Comparative Label-Free Mass Spectrometric Analysis of Mildly versus Severely Affected mdx Mouse Skeletal Muscles Identifies Annexin, Lamin, and Vimentin as Universal Dystrophic Markers
Article Menu

Export Article

Open AccessEditorial
Molecules 2015, 20(7), 12944-12945;

Special Issue—Towards Understanding the Mechanisms and Curing of Muscular Dystrophy Diseases

The Cyprus Institute of Neurology & Genetics, PO Box 23462, 1683 Nicosia, Cyprus
Academic Editor: Derek J. McPhee
Received: 14 July 2015 / Accepted: 16 July 2015 / Published: 16 July 2015
Full-Text   |   PDF [619 KB, uploaded 16 July 2015]


Muscular dystrophies are a heterogeneous group of inherited diseases with different molecular basss, but sharing similar clinical features and dystrophic changes. View Full-Text
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Phylactou, L.A. Special Issue—Towards Understanding the Mechanisms and Curing of Muscular Dystrophy Diseases. Molecules 2015, 20, 12944-12945.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top